Drawing for ZETETIN

USPTO serial 78173076

ZETETIN

Reviewed by CopyMark Law Group

Status 614
Filing date
Status date
Registration date
—
Examiner
BROWN, BRIAN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZETETIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian Gibbons

3936 S SEMORAN BLVD STE 330ORLANDO, FL 32822-4015UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL COMPOSITIONACTIVEOct 8, 2002

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 15, 2004PETDPETITION TO REVIVE-DENIED—
Jun 22, 2004PINMINCOMPLETE PETITION NOTICE MAILED—
Nov 11, 2003PETRPETITION TO REVIVE-RECEIVED—
Oct 29, 2003ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 16, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance